Sponsors (8)
The bill focuses federal attention and coordination on improving lung cancer research and screening for under-recognized groups—potentially improving outcomes—but it delays action for up to two years and may require new funding or congressional action before benefits are realized.
Women at higher risk and other under-recognized patient groups will get a coordinated federal review and updated research/strategy focus that could improve earlier detection, screening uptake, and clinical outcomes for lung cancer.
Veterans, health systems, and researchers will benefit from strengthened federal coordination (HHS, DoD, VA) and multidisciplinary research efforts that may speed development of biomarkers, diagnostics, and environmental/genomic studies.
State and federal policymakers and the public will get a required report to Congress within two years, increasing transparency and creating a clear timeline for recommended program changes.
People who could benefit from improved screening and research will wait up to two years for the mandated review and report, delaying potential earlier diagnosis and treatment improvements.
If the review identifies statutory or program barriers but Congress does not act, recommended improvements may remain unrealized, leaving gaps in screening and care unaddressed.
Implementing review recommendations could require new funding or resource shifts, potentially increasing federal spending or redirecting taxpayer-supported resources.
Based on analysis of 2 sections of legislative text.
Directs HHS, with DoD and VA input, to review federal lung cancer research and programs to address gaps affecting women and low‑risk groups and report recommendations within two years.
Requires the Secretary of Health and Human Services, with input from the Secretaries of Defense and Veterans Affairs, to review and, where appropriate, update federal lung cancer research, prevention, diagnosis, and treatment programs to identify knowledge gaps and improve outcomes for women and populations with few known risk factors, and to improve screening rates among USPSTF-recommended groups. The Secretary must report findings, changes made or recommended, and any statutory or other barriers to specified House and Senate committees within two years of enactment. The Act also establishes an official short title.
Introduced March 26, 2025 by Tina Smith · Last progress June 9, 2026